Preparation of mouse monoclonal antibody for RB1CC1 and its clinical application

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Hama, Yusuke ^a   Chano, Tokuhiro ^a   Inui, Takuma ^a   Matsumoto, Kyoichi ^b   Okabe, Hidetoshi ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b Mikuri Immunology Laboratory   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FOCAL ADHESION KINASE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY N1 216; MONOCLONAL ANTIBODY N1 8; MONOCLONAL ANTIBODY N3 2; MONOCLONAL ANTIBODY N3 42; POLYCLONAL ANTIBODY; RB1 INDUCIBLE COILED COIL 1 PROTEIN; UNCLASSIFIED DRUG; PROTEIN TYROSINE KINASE; RB1CC1 PROTEIN, HUMAN;

ARTICLE; BREAST CANCER; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOLECULAR RECOGNITION; NUCLEOTIDE SEQUENCE; WESTERN BLOTTING; ANIMAL; BREAST TUMOR; CELL STRAIN HEK293; CHEMISTRY; FEMALE; HELA CELL; IMMUNOBLOTTING; METABOLISM; METHODOLOGY; MOUSE; PROGNOSIS; PROTEIN TERTIARY STRUCTURE; TUMOR CELL LINE;

ANIMALS; ANTIBODIES, MONOCLONAL; BREAST NEOPLASMS; CELL LINE, TUMOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; FEMALE; HEK293 CELLS; HELA CELLS; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MICE; PROGNOSIS; PROTEIN STRUCTURE, TERTIARY; PROTEIN-TYROSINE KINASES;

EID: 84857749063     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032052     Document Type: Article

References (21)

1. Gan B, Peng X, Nagy T, Alcaraz A, Gu H, et al. (2006) Role of FIP200 in cardiac and liver development and its regulation of TNFalpha and TSC-mTOR signaling pathways. J Cell Biol 175: 121-133.
2. Wei H, Gan B, Wu X, Guan JL, (2009) Inactivation of FIP200 leads to inflammatory skin disorder, but not tumorigenesis, in conditional knock-out mouse models. J Biol Chem 284: 6004-6013.
3. Chano T, Saji M, Inoue H, Minami K, Kobayashi T, et al. (2006) Neuromuscular abundance of RB1CC1 contributes to the non-proliferating enlarged cell phenotype through both RB1 maintenance and TSC1 degradation. Int J Mol Med 18: 425-432.
4. Gan B, Melkoumian ZK, Wu X, Guan KL, Guan JL, (2005) Identification of FIP200 interaction with the TSC1-TSC2 complex and its role in regulation of cell size control. J Cell Biol 170: 379-389.
5. Ueda H, Abbi S, Zheng C, Guan JL, (2000) Suppression of Pyk2 kinase and cellular activities by FIP200. J Cell Biol 149: 423-430.
6. Abbi S, Ueda H, Zheng C, Cooper LA, Zhao J, et al. (2002) Regulation of focal adhesion kinase by a novel protein inhibitor FIP200. Mol Biol Cell 13: 3178-3191.
7. Hara T, Takamura A, Kishi C, Iemura S, Natsume T, et al. (2008) FIP200, a ULK-interacting protein, is required for autophagosome formation in mammalian cells. J Cell Biol 181: 497-510.
8. Hara T, Mizushima N, (2009) Role of ULK-FIP200 complex in mammalian autophagy: FIP200, a counterpart of yeast Atg17? Autophagy 5: 85-87.
9. Itakura E, Mizushima N, (2010) Characterization of autophagosome formation site by a hierarchical analysis of mammalian Atg proteins. Autophagy 6: 764-776.
10. Morselli E, Shen S, Ruckenstuhl C, Bauer MA, Marino G, et al. (2011) p53 inhibits autophagy by interacting with the human ortholog of yeast Atg17, RB1CC1/FIP200. Cell Cycle 10.
11. Hosokawa N, Hara T, Kaizuka T, Kishi C, Takamura A, et al. (2009) Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy. Mol Biol Cell 20: 1981-1991.
12. Ikebuchi K, Chano T, Ochi Y, Tameno H, Shimada T, et al. (2009) RB1CC1 activates the promoter and expression of RB1 in human cancer. Int J Cancer 125: 861-867.
13. Chano T, Ikegawa S, Kontani K, Okabe H, Baldini N, et al. (2002) Identification of RB1CC1, a novel human gene that can induce RB1 in various human cells. Oncogene 21: 1295-1298.
14. Kontani K, Chano T, Ozaki Y, Tezuka N, Sawai S, et al. (2003) RB1CC1 suppresses cell cycle progression through RB1 expression in human neoplastic cells. Int J Mol Med 12: 767-769.
15. Melkoumian ZK, Peng X, Gan B, Wu X, Guan JL, (2005) Mechanism of cell cycle regulation by FIP200 in human breast cancer cells. Cancer Res 65: 6676-6684.
16. Martin N, Schwamborn K, Urlaub H, Gan B, Guan JL, et al. (2008) Spatial interplay between PIASy and FIP200 in the regulation of signal transduction and transcriptional activity. Mol Cell Biol 28: 2771-2781.
17. Tameno H, Chano T, Ikebuchi K, Ochi Y, Arai A, et al. (2011) Prognostic significance of RB1-inducible coiled-coil 1 in salivary gland cancers. Head Neck.
18. Chano T, Ikebuchi K, Tomita Y, Jin Y, Inaji H, et al. (2010) RB1CC1 together with RB1 and p53 predicts long-term survival in Japanese breast cancer patients. PLoS One 5: e15737.
19. Chano T, Okabe H, Hulette CM, (2007) RB1CC1 insufficiency causes neuronal atrophy through mTOR signaling alteration and involved in the pathology of Alzheimer's diseases. Brain Res 1168: 97-105.
20. Chano T, Ikebuchi K, Ochi Y, Tameno H, Tomita Y, et al. (2010) RB1CC1 activates RB1 pathway and inhibits proliferation and cologenic survival in human cancer. PLoS One 5: e11404.
21. Sarbassov DD, Guertin DA, Ali SM, Sabatini DM, (2005) Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307: 1098-1101.